Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Arm Holdings ADR | ARM | Nov 25, 2024 | 139.68 | +2.71 |
Armada Hoffler Properties | AHH | Nov 25, 2024 | 11.00 | -0.63 |
Armada Hoffler Properties Pref A | AHH-A | Nov 25, 2024 | 23.60 | -0.17 |
Armata Pharmaceuticals | ARMP | Nov 25, 2024 | 2.29 | +1.78 |
Armlogi Holding | BTOC | Nov 25, 2024 | 6.18 | +4.04 |
Armour Residential Reit | ARR | Nov 25, 2024 | 18.81 | +0.64 |
ARMOUR Residential REIT Pref C | ARR-C | Nov 25, 2024 | 22.55 | 0.00 |
Armstrong World Industries | AWI | Nov 25, 2024 | 161.96 | +1.81 |
Arogo Capital Acquisition A | AOGO | Nov 25, 2024 | 11.00 | 0.00 |
Arq | ARQ | Nov 25, 2024 | 7.59 | -3.44 |
Arqit Quantum | ARQQ | Nov 25, 2024 | 17.73 | +37.23 |
Array Technologies | ARRY | Nov 25, 2024 | 7.02 | +5.88 |
ArriVent BioPharma | AVBP | Nov 25, 2024 | 27.50 | +0.18 |
Arrow DJ Global Yield ETF | GYLD | Nov 25, 2024 | 13.00 | +0.82 |
Arrow Electronics | ARW | Nov 25, 2024 | 121.68 | +2.03 |
Arrow Financial | AROW | Nov 25, 2024 | 33.35 | -0.30 |
Arrowhead Pharmaceuticals | ARWR | Nov 25, 2024 | 18.79 | +1.35 |
Arrowmark Financial | BANX | Nov 25, 2024 | 20.86 | +0.10 |
ARS Pharmaceuticals | SPRY | Nov 25, 2024 | 13.71 | -2.07 |
Artelo Biosciences | ARTL | Nov 25, 2024 | 1.11 | 0.00 |
Arteris | AIP | Nov 25, 2024 | 8.50 | +1.55 |
Artesian Resources A | ARTNA | Nov 25, 2024 | 34.82 | +1.43 |
Arthur J. Gallagher & Co | AJG | Nov 25, 2024 | 306.39 | +0.69 |
Artisan Partners Asset Management A | APAM | Nov 25, 2024 | 47.94 | +0.50 |
Artiva Biotherapeutics | ARTV | Nov 25, 2024 | 11.81 | +5.45 |
Artivion | AORT | Nov 25, 2024 | 28.41 | +0.50 |
Arts-Way Manufacturing Co. | ARTW | Nov 25, 2024 | 1.67 | -2.28 |
Arvinas | ARVN | Nov 25, 2024 | 25.15 | -2.75 |
ASA Gold And Precious Metals | ASA | Nov 25, 2024 | 19.76 | -1.74 |
Asana | ASAN | Nov 25, 2024 | 15.71 | -0.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.